BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15611644)

  • 1. Abl oncogene bypasses normal regulation of Jak/STAT activation.
    Limnander A; Rothman PB
    Cell Cycle; 2004 Dec; 3(12):1486-8. PubMed ID: 15611644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. v-Abl signaling disrupts SOCS-1 function in transformed pre-B cells.
    Limnander A; Danial NN; Rothman PB
    Mol Cell; 2004 Aug; 15(3):329-41. PubMed ID: 15304214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JAK-STAT signaling activated by Abl oncogenes.
    Danial NN; Rothman P
    Oncogene; 2000 May; 19(21):2523-31. PubMed ID: 10851051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor suppressor activity of SOCS-1.
    Rottapel R; Ilangumaran S; Neale C; La Rose J; Ho JM; Nguyen MH; Barber D; Dubreuil P; de Sepulveda P
    Oncogene; 2002 Jun; 21(28):4351-62. PubMed ID: 12080466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional involvement of Akt signaling downstream of Jak1 in v-Abl-induced activation of hematopoietic cells.
    Oki S; Limnander A; Danial NN; Rothman PB
    Blood; 2002 Aug; 100(3):966-73. PubMed ID: 12130510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation.
    Danial NN; Losman JA; Lu T; Yip N; Krishnan K; Krolewski J; Goff SP; Wang JY; Rothman PB
    Mol Cell Biol; 1998 Nov; 18(11):6795-804. PubMed ID: 9774693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
    Carlesso N; Frank DA; Griffin JD
    J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway.
    Cooney RN
    Shock; 2002 Feb; 17(2):83-90. PubMed ID: 11837794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Van Waes C; Chen Z
    Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium bovis bacillus Calmette-GuĂ©rin infection promotes SOCS induction and inhibits IFN-gamma-stimulated JAK/STAT signaling in J774 macrophages.
    Imai K; Kurita-Ochiai T; Ochiai K
    FEMS Immunol Med Microbiol; 2003 Nov; 39(2):173-80. PubMed ID: 14625101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK/STAT signal transduction: regulators and implication in hematological malignancies.
    Valentino L; Pierre J
    Biochem Pharmacol; 2006 Mar; 71(6):713-21. PubMed ID: 16426581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The suppressors of cytokine signalling (SOCS).
    Kile BT; Alexander WS
    Cell Mol Life Sci; 2001 Oct; 58(11):1627-35. PubMed ID: 11706989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of JAK-STAT1 signal transduction pathway in lesional skin and monocytes from patients with systemic lupus erythematosus.
    Li J; Zhao S; Yi M; Hu X; Li J; Xie H; Zhu W; Chen M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 36(2):109-15. PubMed ID: 21368418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway.
    Park ES; Kim H; Suh JM; Park SJ; You SH; Chung HK; Lee KW; Kwon OY; Cho BY; Kim YK; Ro HK; Chung J; Shong M
    Mol Endocrinol; 2000 May; 14(5):662-70. PubMed ID: 10809230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jak-STAT signaling induced by the v-abl oncogene.
    Danial NN; Pernis A; Rothman PB
    Science; 1995 Sep; 269(5232):1875-7. PubMed ID: 7569929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Drosophila suppressors of cytokine signaling (SOCS) differentially regulate JAK and EGFR pathway activities.
    Rawlings JS; Rennebeck G; Harrison SM; Xi R; Harrison DA
    BMC Cell Biol; 2004 Oct; 5(1):38. PubMed ID: 15488148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway.
    O'Shea JJ; Gadina M; Schreiber RD
    Cell; 2002 Apr; 109 Suppl():S121-31. PubMed ID: 11983158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT (Janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: differential regulation by acute ethanol via a protein kinase C-dependent mechanism.
    Nguyen VA; Chen J; Hong F; Ishac EJ; Gao B
    Biochem J; 2000 Jul; 349(Pt 2):427-34. PubMed ID: 10880341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.